Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M J Bos

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 2, 2007
[The metabolic syndrome]G M J Bos
Nederlands Tijdschrift Voor Geneeskunde|November 16, 2005
[Improving the health of scientific research in the Netherlands]G M J Bos
The Netherlands Journal of Medicine|August 8, 2002
Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantationD Huugen, H C Schouten, G M J Bos
Bone Marrow Transplantation|May 19, 2006
Graft-versus-tumor effects on murine mammary carcinoma in a model of nonmyeloablative haploidentical stem cell transplantationA Vanclée, M van Gelder, H C Schouten, et al.
Heart (British Cardiac Society)|February 18, 2004
Massive cardiac involvement in acute lymphatic leukemiaB C A M Bekkers, B J A Denarié, G M J Bos
Tissue Antigens|November 22, 2014
Clinical and immunological significance of HLA-E in stem cell transplantation and cancerL Wieten, N M Mahaweni, C E M Voorter, et al.
The Netherlands Journal of Medicine|August 8, 2002
Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancyD Huugen, G M J Bos, M Jansen, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 27, 2005
[Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)]H Lokhorst, P C Huijgens, R Raymakers, et al.
Cytotherapy|April 22, 2006
Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DCE B M van Leeuwen, S Cloosen, B L M G Senden-Gijsbers, et al.
Bone Marrow Transplantation|July 28, 2009
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancerA J H M Fleskens, R I Lalisang, G M J Bos, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|August 2, 2007
[The metabolic syndrome]G M J Bos
Nederlands Tijdschrift Voor Geneeskunde|November 16, 2005
[Improving the health of scientific research in the Netherlands]G M J Bos
The Netherlands Journal of Medicine|August 8, 2002
Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantationD Huugen, H C Schouten, G M J Bos
Bone Marrow Transplantation|May 19, 2006
Graft-versus-tumor effects on murine mammary carcinoma in a model of nonmyeloablative haploidentical stem cell transplantationA Vanclée, M van Gelder, H C Schouten, et al.
Heart (British Cardiac Society)|February 18, 2004
Massive cardiac involvement in acute lymphatic leukemiaB C A M Bekkers, B J A Denarié, G M J Bos
Tissue Antigens|November 22, 2014
Clinical and immunological significance of HLA-E in stem cell transplantation and cancerL Wieten, N M Mahaweni, C E M Voorter, et al.
The Netherlands Journal of Medicine|August 8, 2002
Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancyD Huugen, G M J Bos, M Jansen, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 27, 2005
[Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)]H Lokhorst, P C Huijgens, R Raymakers, et al.
Cytotherapy|April 22, 2006
Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DCE B M van Leeuwen, S Cloosen, B L M G Senden-Gijsbers, et al.
Bone Marrow Transplantation|July 28, 2009
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancerA J H M Fleskens, R I Lalisang, G M J Bos, et al.
Pageof 2